Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149871 (
deep vein thrombosis
)
12,364
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The accuracy of
C-reactive protein
(
CRP
) and D-dimer in detecting
deep venous thrombosis
was compared with phlebography in a consecutive series of 69 patients admitted to hospital due to suspicion of thrombosis in the leg. With a sensitivity of 100%,
C-reactive protein
can exclude the possibility of thrombosis. The sensitivity of D-dimer was too low to exclude the diagnosis. With a high discrimination limit the specificity of D-dimer was 100%, which may confirm the diagnosis. Ideally, screening with
C-reactive protein
and D-dimer could reduce the need of venography by 38%.
...
PMID:[Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis]. 157 35
We determined during the acute stage of myocardial infarction selected fibrinolysis variables (tissue-type plasminogen activator, intrinsic plasminogen activators, tissue-type plasminogen activator inhibition, C1-inactivator) and related the observed changes to changes in two acute phase reactants (
C-reactive protein
, fibrinogen). Acute myocardial injury induce significant increases in blood of tissue-type plasminogen activator inhibition (day one, p less than 0.05),
C-reactive protein
(day three, p less than 0.01), fibrinogen (day six, p less than 0.01), and C1-inactivator (day eight, p less than 0.01). Tissue-type plasminogen activator activity measured as C1-inactivator resistant fibrinolytic activity showed a minimum day two after the acute attack (p less than 0.01), whereas plasminogen activator activities arising from the intrinsic system of fibrinolysis remained constant. The observed changes did not parallel the occurrence of
deep vein thrombosis
indicated by a positive Tc-plasmin test (41% of the patients).
...
PMID:Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI). 244 88
The reliability of D-dimer (NycoCard D-dimer) and CRP (
C-reactive protein
) tests to exclude suspected
deep venous thrombosis
(
DVT
) and pulmonary embolism (PE) was investigated in 116 patients. Venography, ultrasonography or ventilation-perfusion lung scanning was used as the control method in 95, 5, and 14 patients, respectively, and pulmonary angiography in two patients, one of whom also underwent lung scanning, the other venography. Of the 116 patients, 52 had thromboembolism (46
DVT
and 6 PE). The respective sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were 94%, 27%, 85% and 51% for the D-dimer test, and 80%, 53% 76% and 60% for the CRP test. As venous thromboembolism is a life-threatening condition, the NPV of an exclusion test must lie very close to 100 per cent, and thus the study showed neither the D-dimer nor the CRP test to be a satisfactory exclusion test for use in cases of suspected
DVT
or PE.
...
PMID:[Evaluation of analyses for exclusion of suspected thrombosis. Do not rely on the D-dimer test!]. 944 58
The reliability of D-dimer (NycoCard D-dimer) and CRP (
C-reactive protein
) tests to exclude suspected
deep venous thrombosis
(
DVT
) and pulmonary embolism (PE) was investigated in 116 patients. Venography, ultrasonography or ventilation-perfusion lung scanning was used as the control method in 95, 5, and 14 patients, respectively, and pulmonary angiography in two patients, one of whom also underwent lung scanning, the other venography. Of the 116 patients, 52 had thromboembolism (46
DVT
and 6 PE). The respective sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were 94%, 27%, 85% and 51% for the D-dimer test, and 80%, 53% 76% and 60% for the CRP test. As venous thromboembolism is a life-threatening condition, the NPV of an exclusion test must lie very close to 100 per cent, and thus the study showed neither the D-dimer nor the CRP test to be a satisfactory exclusion test for use in cases of suspected
DVT
or PE.
...
PMID:[Evaluation of analyses to exclude suspected thrombosis. Don't rely on the D-dimer test!]. 953 50
The role of
C-reactive protein
(
CRP
) in the diagnosis of suspected
deep vein thrombosis
(
DVT
) and a possible advantage of its additional evaluation with D-dimer has not been clearly evaluated. We therefore studied plasma
CRP
and D-dimer levels in 233 consecutive patients with suspected
DVT
; the final diagnosis was based on the results of colour duplex ultrasound or venography.
DVT
was diagnosed in 31.3%.
CRP
and D-dimer correlated significantly (r = 0.64, P < 0.01); both were increased significantly in patients suffering from
DVT
(P < 0.001). Multivariate analysis revealed a significant influence of the presence of
DVT
(P < 0.001), the presence of malignancy (P < 0.001) and the presence of inflammatory diseases (P = 0.009) on plasma
CRP
, while there was no significant influence of the duration of symptoms (P = 0.30). The sensitivity (75% vs 93%) to specificity (69% vs 55%) relationship showed inferior results for
CRP
compared with D-dimer; its additional evaluation did not improve the diagnostic value of D-dimer. We conclude that
CRP
can provide additional information neither for the diagnostic process in patients with suspected
DVT
nor for the differential diagnosis of
DVT
and inflammatory diseases.
...
PMID:C-reactive protein in the diagnosis of deep vein thrombosis. 1240 73
Deep venous thrombosis
(
DVT
) rarely occurs in active children. Its presence usually suggests an inherited or acquired hypercoagulable state. Occasionally mechanical obstruction may be the inciting factor in this process. Initial management usually consists of sequential heparin and warfarin anticoagulation. We present the management of
DVT
in an adolescent girl with elevated levels of
C-reactive protein
and lupus anticoagulant. Venous claudication and severe lower-extremity swelling on ambulation complicated her course. After more than 2 weeks of conservative therapy with anticoagulation thrombolytic therapy was instituted. This was terminated early because of mild hematuria. However, follow-up duplex scan at 2 years has shown complete resolution of the iliofemoral thrombosis. Spontaneous
DVT
in children differ from that in adults in that an underlying etiology can usually be uncovered. These differences are explored.
...
PMID:Venous claudication in a child with thrombophilia. 1246 15
A 54-year-old man of Persian origin presented to our department with a 1-year history of ulcers on the right leg that had been unresponsive to numerous topical treatments, accompanied by lymphedema of the right leg. Medical history included hypergonadotropic hypogonadism, which had not been further investigated. He was treated for 20 years with testosterone IM once monthly, which he stopped a year before the current hospitalization for unclear reasons. The patient reported no congenital lymphedema. Physical examination revealed two deep skin ulcers (Figure 1) on the right leg measuring 10 cm in diameter with raised irregular inflammatory borders and a boggy, necrotic base discharging a purulent hemorrhagic exudate. Bilateral leg pitting edema and right lymphangitis with lymphadenitis were noted. He had low head hair implantment, sparse hair on the body and head, hyperpigmentation on both legs, onychodystrophia of the toenails (mainly the large toe and less prominent on the other toes), which was atrophic lichen-planus-like in appearance and needed no trimming (Figure 2), normal hand nails, oral thrush, and angular cheilitis. Other physical findings were gynecomastia, pectus excavatum, small and firm testicles, long extremities, asymmetrical goiter, systolic murmur 2/6 in left sternal border, and slow and inappropriate behavior. The patient's temperature on admission was 39 degrees C. Blood cultures were negative for bacterial growth. Results of laboratory investigations included hemoglobin (11.2 g/dL), hematocrit (26.8%), normal mean corpuscular volume and mean corpuscular hemoglobin volume, and red blood cell distribution width (16%). Blood smear showed spherocytes, slight hypochromia, anisocytosis, macrocytosis, and microcytosis. Blood chemistry values were taken for iron (4 micro g/dL [normal range 40-150 micro g/dL]), transferrin (193 mg/dL [normal range 220-400 mg/dL]), ferritin (1128 ng/mL [normal range 14-160 ng/mL]), transferrin saturation (1.5% [normal range 20%-55%]), serum folate (within normal limits), and vitamin B12 (within normal limits). Direct Coombs' test equaled positive 2 + IgG. All these values indicated anemia of chronic diseases combined with hemolytic anemia. Further blood work-up tested antinuclear antibody (positive <1:80 homogeneous pattern), rheumatoid factors (143 IU/mL [positive >8.5 IU/mL]),
C-reactive protein
(286 mg/L [normal range 0-5 mg/L]), anticardiolipin IgM antibody (9.0 monophosphoryl lipid U/mL [normal range 0-7.00 MPL U/mL]) and antithrombin III activity (135% [normal range 74%-114%]). Results of other blood tests were within normal limits or negative, including lupus anticoagulant, beta2 glycoprotein, anticardiolipin IgG Ab, anti-ss DNA Ab, C3, C4, anti-RO, anti-LA, anti-SC-70, anti-SM Ab, P-ANCA, C-ANCA, TSH, FT4, anti-T microsomal, antithyroglobulin, protein C activity, protein S free, cryoglobulins, serum immunoelectrophoresis, VDRL, hepatitis C antibodies, hepatitis B antigen, and human immunodeficiency virus. Endocrinological work-up examined luteinizing hormone (22.9 mIU/mL [normal range for adult men 0.8-6 mIU/mL]), follicle stimulating hormone (49.7 mIU/mL [normal range for adult men 1-11 mIU/mL]), testosterone (0.24 ng/mL [normal range for adult men 2.5-8.0 ng/mL]), bioavailable testosterone (0.02 ng/mL [normal range for adult men >0.6 ng/mL]), and percent bioavailable test (8.1% [normal value >20%]). These results indicate hypergonadotropic hypogonadism. Plasminogen activator inhibitor 1 was 6 U (normal value 5-20 U/mL). Karyotyping performed by G-banding technique revealed a 47 XXY karyotype, which is diagnostic of Klinefelter's syndrome. Doppler ultrasound of the leg ulcers disclosed partial thrombus in the distal right femoral vein. X-rays and bone scan displayed osteomyelitis along the right tibia. Histological examination of a 4-mm punch biopsy from the ulcer border revealed hyperkeratosis, acanthosis, hypergranulosis, and mixed inflammatory infiltrate containing eosinophils compatible with chronic ulcer. Multiple vessels were seen, compatible with a healing process. Direct immunofluorescence of the biopsy revealed granular IgM in the dermo-epidermal junction. Indirect immunofluorescence was negative. Thyroid function tests showed normal thyroid stimulating hormone and free throxine4. Multinodular goiter was seen on thyroid scan and ultrasound. Thyroid fine needle aspiration was compatible with multinodular goiter (normal follicular cells, free colloid, macrophages with pigment). IV treatment with amoxicillin-clavulanic acid 1 g t.i.d. was administered for 2 weeks, with a decrease in temperature and normalization of the leukocyte level. Oral antibiotic treatment with amoxicillin-clavulanic acid was continued for 10 more days, followed by 25 days of ciprofloxacin for the osteomyelitis. Local treatment included saline soakings followed by application of Promogran (Johnson & Johnson, New Brunswick, NJ) and Kaltostat (ConvaTec Ltd., a Bristol-Myers Squibb Company, New York, NY) with slight improvement. At the same time, the patient was treated with warfarin sodium due to
deep vein thrombosis
under international normalized ratio 2-3. The patient was treated with IM testosterone once monthly for 1 year, which resulted in a reduction in the diameter and depth of the leg ulcers (Figure 3). Blood tests were not performed for follow-up of the immune state.
...
PMID:Klinefelter's syndrome presenting with leg ulcers. 1536 65
The role of
C-reactive protein
(
CRP
) in venous thromboembolism (VTE) is still under discussion because of controversial results in the literature. Conflicting data may have partly been due to bias by exogenous factors altering
CRP
levels. We investigated
CRP
concentrations in patients with spontaneous VTE applying a study design that allowed the measurement of basal high sensitivity (hs)-
CRP
levels. Patients with a history of
deep vein thrombosis
(
DVT
, n=117) and pulmonary embolism (PE, n=97) were compared to healthy individuals (n=104). Hs-
CRP
levels (mg/dl) were significantly higher in patients (n=214, median/interquartile range: 0.171/0.082-0.366) than in controls (0.099/0.053-0.245, p=0.001). The unadjusted odds ratio (OR) for VTE per 1 mg/dl increase of
CRP
was 2.8 [95% confidence interval (CI): 1.1-6.8, p=0.03]. This association remained significant after adjustment for factor V Leiden, prothrombin G20210A and factor VIII activity above 230% (OR = 2.9, 95% CI [1.1-7.5]), but became remarkably attenuated and lost its statistical significance after adjustment for BMI alone (OR = 1.7 [0.7-4.0]).
CRP
was also not independently associated with VTE in subgroups of patients (those with
DVT
without symptomatic PE, those with PE and patients without established risk factor) in multiple regression analysis. In summary, we observed significantly higher basal hs-
CRP
levels in patients with spontaneous VTE compared to healthy controls. This association was independent of hereditary and laboratory risk factors for VTE, but lost its significance after adjustment for BMI. Increased basal
CRP
levels do not appear to represent an independent risk factor for VTE.
...
PMID:Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. 1573 99
During the past decade, the role of inflammation in the pathophysiology of arterial thrombosis has been elucidated. However, comparatively little is known about the relationship between inflammation and venous thrombosis. The aim of this study was to perform a systematic review of clinical studies that have examined the association between inflammation and venous thrombosis, specifically: (1) the value of inflammatory markers in predicting the future development of venous thrombosis; (2) test characteristics of markers of inflammation in the diagnosis of acute venous thrombosis; and (3) effect of venous thrombosis on blood levels of inflammatory markers. Using keywords venous thrombosis, venous thromboembolism, inflammation, acute phase markers,
C-reactive protein
(
CRP
), interleukin (IL)-6, IL-8, and monocyte chemotactic protein (MCP)-1, PubMed and Medline computerized databases were searched for English language articles published after 1980. Search results were restricted to clinical studies in humans that used study designs that were appropriate to address the above objectives. Results show that plasma
CRP
levels do not appear to predict risk of future venous thrombosis (two studies; N = 41,308). Four studies (N=562) have examined the utility of plasma
CRP
in the diagnosis of venous thrombosis; pooled positive and negative predictive values were 53% (95% CI:47%,59%) and 85% (95% CI: 81%, 89%), respectively. A two- to six-fold increase in the risk of
deep vein thrombosis
(
DVT
) is associated with elevations in plasma levels of
CRP
, IL-6, IL-8, MCP-1 or TNF-alpha (three studies). We can conclude that the nature of the relationship between inflammation and clinical venous thrombosis is not yet established.
CRP
does not appear to be useful in predicting future venous thrombosis or in the diagnosis of acute venous thrombosis. While several markers of inflammation are elevated in acute venous thrombosis, further research is needed to determine the precise relationship between these markers and venous thrombosis. The identification and elucidation of inflammatory markers relevant to venous thrombosis could provide targets for future therapy.
...
PMID:The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. 1611 26
High levels of factor XI have been implicated as a risk factor for
deep venous thrombosis
and possibly cardiovascular disease; however, the relationship between elevated factor XI activity and stroke has yet to be established. We retrospectively evaluated factor XI activity, factor XI antigen, and high-sensitivity
C-reactive protein
(hs-CRP) values in samples from 65 patients with stroke, 13 with transient ischemic attack (TIA), and 17 with venous thrombosis, younger than 55 years with normal prothrombin and partial thromboplastin times who underwent evaluation for a hypercoagulable state. Factor XI activity levels were more than normal in 22% of patients with stroke or TIA and 18% of patients with venous thrombosis, producing odds ratios of 5.3 and 4.1 for stroke or TIA and venous thrombosis, respectively. Factor XI activity levels correlate with factor XI antigen levels by Deming regression analysis (slope, 1.3; R = 0.667) and a lack of correlation of both with hs-CRP suggests that factor XI is not an acute phase reactant. Our findings suggest an association between elevated factor XI activity and stroke.
...
PMID:Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. 1688 Jan 42
1
2
3
4
5
6
7
Next >>